Pradžia › Opinis kolitas › Ilinoisas › Chicago
Opinis kolitas klinikiniai tyrimai Chicago, IL
15 tyrimai dėl Opinis kolitas ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Renkami dalyviai3 fazė
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Renkami dalyviai2 fazė
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Renkami dalyviai2 fazė
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Renkami dalyviai2 fazė
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Renkami dalyviai3 fazė
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Renkami dalyviai2 fazė
- Northwestern University, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Renkami dalyviai2 fazė
- Rush University Medical Center, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Renkami dalyviai2 fazė
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Renkami dalyviai4 fazė
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Renkami dalyviai3 fazė
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Renkami dalyviai
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Renkami dalyviaiStebimasis tyrimas
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Renkami dalyviai2 fazė
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Renkami dalyviai2 fazė
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Renkami dalyviai
- University of Chicago, Chicago
Opinis kolitas tyrimai kituose miestuose
- New York City, NY23 tyrimai
- Orlando, FL22 tyrimai
- Miami, FL21 tyrimas
- Houston, TX17 tyrimai
- San Antonio, TX16 tyrimai
- Tacoma, WA15 tyrimai
- San Diego, CA15 tyrimai
- Tyler, TX14 tyrimai
- Colorado Springs, CO14 tyrimai
- Los Angeles, CA13 tyrimai
- St. Louis, MO13 tyrimai
- Washington, DC12 tyrimai
Kiti tyrimai Chicago
- Nedidelinių ląstelių plaučių vėžys61 tyrimas
- Krūties vėžys58 tyrimai
- Vėžys (visų tipų)51 tyrimas
- Metastatinis vėžys45 tyrimai
- Prostatos vėžys45 tyrimai
- Nutukimas41 tyrimas
- Plaučių vėžys41 tyrimas
- Kiaušidžių vėžys36 tyrimai
- Insultas34 tyrimai
- Storosios ir tiesiosios žarnos vėžys33 tyrimai
- Širdies nepakankamumas31 tyrimas
- Antsvoris28 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.